Semaglutide offers several benefits that are helpful for patients with chronic kidney disease, including: Lowering blood sugar without increasing the risk of low blood sugar Supporting steady weight loss, which helps ease pressure on the kidneys Slowing digestion and reducing appetite, leading to improved blood sugar control Reducing inflammation, which is known to make chronic kidney disease worse Helping protect blood vessels, including those in the kidneys These effects combine to create a treatment that may slow down the loss of kidney function in people with diabetes and early-stage chronic kidney disease
Select your current weight 286 pounds 130 175 220 265 310 355 395 440 Weight you could lose 57 pounds *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
Its main effects: Signals your brain that youre full Slows down stomach emptying Promotes insulin release and lowers blood sugar Reduces appetite and cravings Tirzepatide works slightly differently because its a dual agonist meaning it mimics both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), another hormone involved in appetite regulation and glucose control
If you arent losing weight at the desired speed, your provider will slowly escalate it every month until you reach the maximum dosage of 2.4mg again, only going up that high if its needed
